FINANCIAL CONSIDERATIONS
• Combined company positioned for strong growth profile and sustained value creation
• FY2018 revenues of $1.6 million (Curetis) and $2.9 million (OpGen)
• Estimated FY2019 combined revenue of $5-6 million
• Estimated 2020 combined revenue of $10-15 million
• Net loss from operations and cash burn anticipated to decrease starting in 2020 due to
operating synergies from combined corporate, manufacturing & distribution, R&D, and
sales & marketing organizations
• Approximately 130 employees post-deal closing domestic and international
• Transaction close contingent on completing interim equity financing as well as debt
holder and shareholder approvals from both existing companies
• OpGen has committed to raise interim capital of $10 million in 2H 2019
©2019 OpGen, Inc. & Curetis N.V.